Picture of Hugel logo

145020 — Hugel News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Sichuan Pharma jumps most in 13 months as CBC dispute settles, Jefferies upgrades

** Shares of Sihuan Pharmaceutical  0460.HK  soar 21.3% to
HK$1.94, biggest daily pct gain since January 2021 
    ** Stock hit highest since Sept. 27 and on course to snap
two sessions of decline; top gainer in Hang Seng Composite Index
 .HSCI  and second biggest gainer on the Hong Kong bourse
    ** Sihuan says it has reached settlement with CBC Group
regarding a lawsuit in China  urn:newsml:reuters.com:*:nFWN2UO01K
    ** Says CBC has completed its acquisition of Hugel Inc
 145020.KQ  and now holding 42.9% stake 
    ** Sihuan says the continued strategic collaboration between
the company and Hugel is mutually beneficial to all three
parties including CBC    
    ** Jefferies upgrades Sihuan to "buy" from "hold" and lifts
PT to HK$3.5 from HK$1.67, on expecting its distribution
contract with Hugel to be honored as the dispute has been
settled between Sihuan and CBC
    ** Sihuan, CBC and Hugel have decided to work together to
maximize the benefit for its shareholders in terms of Sihuan's
distribution rights for Hugel's BTX and other medical aesthetic
products in China - Jefferies 
    ** Hang Seng Commerce & Industry Index  .HSNC  eases 0.4%
and the healthcare index  .HSCIH  surges 4.4% 
    ** Hang Seng Composite Index  .HSCI  eases 0.6% and Hang
Seng Index  .HSI  slips 1%


 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))

Recent news on Hugel

See all news